{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:41:33Z","timestamp":1772264493605,"version":"3.50.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T00:00:00Z","timestamp":1444694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s10792-015-0137-8","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T23:48:17Z","timestamp":1444780097000},"page":"139-146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Systemic cyclosporine and corneal transplantation"],"prefix":"10.1007","volume":"36","author":[{"given":"Mohammed","family":"Ziaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Ziaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bita","family":"Manzouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,13]]},"reference":[{"issue":"10","key":"137_CR1","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archopht.1992.01080220054021","volume":"110","author":"The collaborative corneal transplantation studies (CCTS)","year":"1992","unstructured":"The collaborative corneal transplantation studies (CCTS) (1992) Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group. Arch Ophthalmol 110(10):1392\u20131403","journal-title":"Arch Ophthalmol"},{"key":"137_CR2","unstructured":"Bradley BA et al (1993) Penetrating keratoplasty in the United Kingdom: an interim analysis of the corneal transplant follow-up study. Clin Transpl 293\u2013315"},{"key":"137_CR3","unstructured":"Williams KA et al (2006) The Australian corneal graft registry 2004 annual report. http:\/\/hdl.handle.net\/2328\/1002"},{"issue":"9","key":"137_CR4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/bjo.86.9.945","volume":"86","author":"JC Hill","year":"2002","unstructured":"Hill JC (2002) High risk corneal grafting. Br J Ophthalmol 86(9):945","journal-title":"Br J Ophthalmol"},{"key":"137_CR5","doi-asserted-by":"crossref","unstructured":"Khodadoust AA (1973) The allograft rejection reaction: the leading cause of late failure of clinical corneal grafts. In: Corneal graft failure. Ciba Foundation Symposium 15, new series. Elsevier. pp. 151\u201367","DOI":"10.1002\/9780470719985.ch9"},{"issue":"5","key":"137_CR6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jama.1988.03720050055023","volume":"259","author":"Report of the organ transplant panel","year":"1988","unstructured":"Report of the organ transplant panel (1988) Corneal transplantation. Council on scientific affairs. JAMA 259(5):719\u2013722","journal-title":"JAMA"},{"issue":"2","key":"137_CR7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-2008-1050995","volume":"187","author":"F Hoffmann","year":"1985","unstructured":"Hoffmann F, Wiederholt M (1985) Local treatment of corneal transplants in the human with cyclosporin A. Klin Monbl Augenheilkd 187(2):92\u201396","journal-title":"Klin Monbl Augenheilkd"},{"issue":"4","key":"137_CR8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01973261","volume":"6","author":"JF Borel","year":"1976","unstructured":"Borel JF et al (1976) Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 6(4):468\u2013475","journal-title":"Agents Actions"},{"issue":"8357","key":"137_CR9","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(83)90978-9","volume":"2","author":"European Multicentre Trial Group","year":"1983","unstructured":"European Multicentre Trial Group (1983) Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial. Lancet 2(8357):986\u2013989","journal-title":"Lancet"},{"issue":"8151","key":"137_CR10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(79)92440-1","volume":"2","author":"RY Calne","year":"1979","unstructured":"Calne RY et al (1979) Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 2(8151):1033\u20131036","journal-title":"Lancet"},{"issue":"2","key":"137_CR11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s004170000242","volume":"239","author":"I Claerhout","year":"2001","unstructured":"Claerhout I et al (2001) The effect of duration and timing of systemic cyclosporine therapy on corneal allograft survival in a rat model. Graefes Arch Clin Exp Ophthalmol 239(2):152\u2013157","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"137_CR12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0039-6257(86)90035-4","volume":"31","author":"RB Nussenblatt","year":"1986","unstructured":"Nussenblatt RB, Palestine AG (1986) Cyclosporine: immunology, pharmacology and therapeutic uses. Surv Ophthalmol 31(3):159\u2013169","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"137_CR13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00003226-198605030-00001","volume":"5","author":"F Hoffmann","year":"1986","unstructured":"Hoffmann F, Wiederholt M (1986) Topical cyclosporin A in the treatment of corneal graft reaction. Cornea 5(3):129","journal-title":"Cornea"},{"issue":"25","key":"137_CR14","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM198912213212507","volume":"321","author":"BD Kahan","year":"1989","unstructured":"Kahan BD (1989) Cyclosporine. N Engl J Med 321(25):1725\u20131738","journal-title":"N Engl J Med"},{"issue":"3","key":"137_CR15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00003226-199007000-00002","volume":"9","author":"MW Belin","year":"1990","unstructured":"Belin MW, Bouchard CS, Phillips TM (1990) Update on topical cyclosporin A. Background, immunology, and pharmacology. Cornea 9(3):184\u2013195","journal-title":"Cornea"},{"issue":"5","key":"137_CR16","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/hlca.19760590509","volume":"59","author":"TJ Petcher","year":"1976","unstructured":"Petcher TJ, Weber H, Ruegger A (1976) Crystal and molecular structure of an iodo-derivative of the cyclic undecapeptide cyclosporin A. Helv Chim Acta 59(5):1480\u20131489","journal-title":"Helv Chim Acta"},{"issue":"10","key":"137_CR17","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1517\/14656566.5.10.2099","volume":"5","author":"HD Perry","year":"2004","unstructured":"Perry HD, Donnenfeld ED (2004) Topical 0.05% cyclosporin in the treatment of dry eye. Expert Opin Pharmacother 5(10):2099\u20132107","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"137_CR18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/02713689408995775","volume":"13","author":"U Pleyer","year":"1994","unstructured":"Pleyer U et al (1994) Ocular absorption of cyclosporine A from liposomes incorporated into collagen shields. Curr Eye Res 13(3):177\u2013181","journal-title":"Curr Eye Res"},{"key":"137_CR19","first-page":"118","volume":"90","author":"U Pleyer","year":"1993","unstructured":"Pleyer U et al (1993) Verteilung von Cyclophilin in okul\u00e4ren Geweben. Ophthalmologe 90:118","journal-title":"Ophthalmologe"},{"issue":"6","key":"137_CR20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0167-5699(93)90048-P","volume":"14","author":"J Liu","year":"1993","unstructured":"Liu J (1993) FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. Immunol Today 14(6):290\u2013295","journal-title":"Immunol Today"},{"issue":"9","key":"137_CR21","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1073\/pnas.89.9.3686","volume":"89","author":"DA Fruman","year":"1992","unstructured":"Fruman DA et al (1992) Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci USA 89(9):3686\u20133690","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"137_CR22","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0041-1345(98)00577-6","volume":"30","author":"PF Halloran","year":"1998","unstructured":"Halloran PF, Kung L, Noujaim J (1998) Calcineurin and the biological effect of cyclosporine and tacrolimus. Transplant Proc 30(5):2167\u20132170","journal-title":"Transplant Proc"},{"issue":"5","key":"137_CR23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1083\/jcb.200111073","volume":"156","author":"V Horsley","year":"2002","unstructured":"Horsley V, Pavlath GK (2002) NFAT: ubiquitous regulator of cell differentiation and adaptation. J Cell Biol 156(5):771\u2013774","journal-title":"J Cell Biol"},{"issue":"16","key":"137_CR24","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2174\/0929867033457160","volume":"10","author":"PC Waldmeier","year":"2003","unstructured":"Waldmeier PC et al (2003) Cyclophilin D as a drug target. Curr Med Chem 10(16):1485\u20131506","journal-title":"Curr Med Chem"},{"issue":"4","key":"137_CR25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.iio.0000212135.77675.6a","volume":"46","author":"GN Foulks","year":"2006","unstructured":"Foulks GN (2006) Topical cyclosporine for treatment of ocular surface disease. Int Ophthalmol Clin 46(4):105\u2013122","journal-title":"Int Ophthalmol Clin"},{"issue":"4","key":"137_CR26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0002-9394(03)00326-X","volume":"136","author":"AM Avunduk","year":"2003","unstructured":"Avunduk AM et al (2003) The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol 136(4):593\u2013602","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"137_CR27","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0161-6420(94)31138-9","volume":"101","author":"MG Maguire","year":"1994","unstructured":"Maguire MG et al (1994) Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology 101(9):1536\u20131547","journal-title":"Ophthalmology"},{"issue":"2","key":"137_CR28","first-page":"208","volume":"29","author":"C Newton","year":"1988","unstructured":"Newton C, Gebhardt BM, Kaufman HE (1988) Topically applied cyclosporine in azone prolongs corneal allograft survival. Invest Ophthalmol Vis Sci 29(2):208\u2013215","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"137_CR29","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/ICO.0b013e318160602d","volume":"27","author":"KC Yoon","year":"2008","unstructured":"Yoon KC et al (2008) Effect of topical cyclosporin A on herpetic stromal keratitis in a mouse model. Cornea 27(4):454\u2013460","journal-title":"Cornea"},{"issue":"4","key":"137_CR30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ajo.2005.11.042","volume":"141","author":"SN Rao","year":"2006","unstructured":"Rao SN (2006) Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topical cyclosporine 0.05%. Am J Ophthalmol 141(4):771\u2013772","journal-title":"Am J Ophthalmol"},{"key":"137_CR31","doi-asserted-by":"crossref","first-page":"230386","DOI":"10.1155\/2012\/230386","volume":"2012","author":"D Tedesco","year":"2012","unstructured":"Tedesco D, Haragsim L (2012) Cyclosporine: a review. J Transplant 2012:230386","journal-title":"J Transplant"},{"issue":"6","key":"137_CR32","first-page":"637","volume":"26","author":"S Scheer","year":"2003","unstructured":"Scheer S et al (2003) Immunosuppression in corneal transplantation. J Fr Ophtalmol 26(6):637\u2013647","journal-title":"J Fr Ophtalmol"},{"issue":"1","key":"137_CR33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000048289","volume":"216","author":"E Bertelmann","year":"2002","unstructured":"Bertelmann E, Jaroszewski J, Pleyer U (2002) Corneal allograft rejection: current understanding. 2. Clinical implications. Ophthalmologica 216(1):2\u201312","journal-title":"Ophthalmologica"},{"key":"137_CR34","first-page":"2409","volume":"15","author":"AJ Wood","year":"1983","unstructured":"Wood AJ et al (1983) Cyclosporine: pharmacokinetics, metabolism, and drug interactions. Transplant Proc 15:2409\u20132414","journal-title":"Transplant Proc"},{"issue":"2","key":"137_CR35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","volume":"4","author":"M Naesens","year":"2009","unstructured":"Naesens M, Kuypers DR, Sarwal M (2009) Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 4(2):481\u2013508","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"137_CR36","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/FTD.0b013e3181e44244","volume":"32","author":"DA Hesselink","year":"2010","unstructured":"Hesselink DA, Bouamar R, van Gelder T (2010) The pharmacogenetics of calcineurin inhibitor-related nephrotoxicity. Ther Drug Monit 32(4):387\u2013393","journal-title":"Ther Drug Monit"},{"issue":"4","key":"137_CR37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004397-199303340-00005","volume":"33","author":"MD Smet de","year":"1993","unstructured":"de Smet MD, Nussenblatt RB (1993) Clinical use of cyclosporine in ocular disease. Int Ophthalmol Clin 33(4):31\u201345","journal-title":"Int Ophthalmol Clin"},{"key":"137_CR38","first-page":"2438","volume":"15","author":"P Keown","year":"1983","unstructured":"Keown P, Stiller C, Sinclair NR et al (1983) The clinical relevance of cyclosporine blood levels as measured by radioimmunoassay. Transplant Proc 15:2438\u20132441","journal-title":"Transplant Proc"},{"issue":"1","key":"137_CR39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/108076802317233243","volume":"18","author":"J Theng","year":"2002","unstructured":"Theng J et al (2002) Distribution of cyclosporin A in the cornea after topical or oral administration. J Ocul Pharmacol Ther 18(1):83\u201388","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"137_CR40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.survophthal.2007.04.008","volume":"52","author":"A Panda","year":"2007","unstructured":"Panda A et al (2007) Corneal graft rejection. Surv Ophthalmol 52(4):375\u2013396","journal-title":"Surv Ophthalmol"},{"issue":"3 Suppl 3","key":"137_CR41","first-page":"759","volume":"20","author":"MJ Mihatsch","year":"1988","unstructured":"Mihatsch MJ, Thiel G, Ryffel B (1988) Histopathology of cyclosporine nephrotoxicity. Transplant Proc 20(3 Suppl 3):759\u2013771","journal-title":"Transplant Proc"},{"issue":"3 Suppl 3","key":"137_CR42","first-page":"623","volume":"20","author":"SJ Munoz","year":"1988","unstructured":"Munoz SJ et al (1988) Elevated arterial blood pressure in survivors of liver transplantation treated with cyclosporine and corticosteroids. Transplant Proc 20(3 Suppl 3):623\u2013627","journal-title":"Transplant Proc"},{"issue":"3 Suppl 3","key":"137_CR43","first-page":"859","volume":"20","author":"W Vine","year":"1988","unstructured":"Vine W et al (1988) Cyclosporine-induced hepatotoxicity: a microassay by hepatocytes in tissue culture. Transplant Proc 20(3 Suppl 3):859\u2013862","journal-title":"Transplant Proc"},{"issue":"3","key":"137_CR44","first-page":"136","volume":"10","author":"S Boubenider","year":"1997","unstructured":"Boubenider S et al (1997) Incidence and consequences of post-transplantation lymphoproliferative disorders. J Nephrol 10(3):136\u2013145","journal-title":"J Nephrol"},{"issue":"1","key":"137_CR45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/14740338.7.1.79","volume":"7","author":"S Kashani","year":"2008","unstructured":"Kashani S, Mearza AA (2008) Uses and safety profile of ciclosporin in ophthalmology. Expert Opin Drug Saf 7(1):79\u201389","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"137_CR46","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/bjo.86.9.988","volume":"86","author":"S Rumelt","year":"2002","unstructured":"Rumelt S et al (2002) Systemic cyclosporin A in high failure risk, repeated corneal transplantation. Br J Ophthalmol 86(9):988\u2013992","journal-title":"Br J Ophthalmol"},{"key":"137_CR47","volume-title":"Textbook of ocular pharmacology","author":"TJ Zimmerman","year":"1977","unstructured":"Zimmerman TJ (1977) Textbook of ocular pharmacology. Lippincott-Raven, Washington"},{"key":"137_CR48","doi-asserted-by":"crossref","unstructured":"Lee JJ, Kim MK, Wee WR (2015) Adverse effects of low-dose systemic cyclosporine therapy in high-risk penetrating keratoplasty. Graefes Arch Clin Exp Ophthalmol 253(7):1111\u20131119","DOI":"10.1007\/s00417-015-3008-0"},{"issue":"6","key":"137_CR49","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0161-6420(93)31558-7","volume":"100","author":"JK Milani","year":"1993","unstructured":"Milani JK et al (1993) Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye. Ophthalmology 100(6):890\u2013896","journal-title":"Ophthalmology"},{"issue":"4","key":"137_CR50","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/jop.1995.11.509","volume":"11","author":"BM Gebhardt","year":"1995","unstructured":"Gebhardt BM, Varnell ED, Kaufman HE (1995) Cyclosporine in collagen particles: corneal penetration and suppression of allograft rejection. J Ocul Pharmacol Ther 11(4):509\u2013517","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"137_CR51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00172265","volume":"229","author":"K Mahlberg","year":"1991","unstructured":"Mahlberg K et al (1991) Prevention of experimental corneal allograft rejection in rabbits using cyclosporin-collagen shields. Graefes Arch Clin Exp Ophthalmol 229(1):69\u201374","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"137_CR52","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0002-9394(14)75976-8","volume":"109","author":"YF Chen","year":"1990","unstructured":"Chen YF et al (1990) Cyclosporine-containing collagen shields suppress corneal allograft rejection. Am J Ophthalmol 109(2):132\u2013137","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"137_CR53","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/02713689508998493","volume":"14","author":"A Apel","year":"1995","unstructured":"Apel A et al (1995) A subconjunctival degradable implant for cyclosporine delivery in corneal transplant therapy. Curr Eye Res 14(8):659\u2013667","journal-title":"Curr Eye Res"},{"issue":"5","key":"137_CR54","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1167\/iovs.06-0985","volume":"48","author":"SS Lee","year":"2007","unstructured":"Lee SS et al (2007) A pharmacokinetic and safety evaluation of an episcleral cyclosporine implant for potential use in high-risk keratoplasty rejection. Invest Ophthalmol Vis Sci 48(5):2023\u20132029","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"137_CR55","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1167\/iovs.02-1112","volume":"44","author":"JT Theng","year":"2003","unstructured":"Theng JT et al (2003) Pharmacokinetic and toxicity study of an intraocular cyclosporine DDS in the anterior segment of rabbit eyes. Invest Ophthalmol Vis Sci 44(11):4895\u20134899","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"137_CR56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0161-6420(98)91176-9","volume":"105","author":"GJ Jaffe","year":"1998","unstructured":"Jaffe GJ et al (1998) Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis. Ophthalmology 105(1):46\u201356","journal-title":"Ophthalmology"},{"issue":"3","key":"137_CR57","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archopht.1996.01100130307014","volume":"114","author":"PA Pearson","year":"1996","unstructured":"Pearson PA et al (1996) Evaluation of a delivery system providing long-term release of cyclosporine. Arch Ophthalmol 114(3):311\u2013317","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"137_CR58","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/archopht.1981.03930020514024","volume":"99","author":"JD Salisbury","year":"1981","unstructured":"Salisbury JD, Gebhardt BM (1981) Suppression of corneal allograft rejection by cyclosporin A. Arch Ophthalmol 99(9):1640\u20131643","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"137_CR59","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/jop.1991.7.221","volume":"7","author":"D Wakefield","year":"1991","unstructured":"Wakefield D, McCluskey P (1991) Cyclosporine: a therapy in inflammatory eye disease. J Ocul Pharmacol 7(3):221\u2013226","journal-title":"J Ocul Pharmacol"},{"issue":"2","key":"137_CR60","first-page":"212","volume":"33","author":"CP Herbort","year":"1989","unstructured":"Herbort CP et al (1989) Penetrating keratoplasty in the rat: a model for the study of immunosuppressive treatment of graft rejection. Jpn J Ophthalmol 33(2):212\u2013220","journal-title":"Jpn J Ophthalmol"},{"issue":"8144","key":"137_CR61","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0140-6736(79)92082-8","volume":"2","author":"DJ Coster","year":"1979","unstructured":"Coster DJ et al (1979) Prolonged survival of corneal allografts in rabbits treated with cyclosporin A. Lancet 2(8144):688\u2013689","journal-title":"Lancet"},{"issue":"5","key":"137_CR62","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bjo.66.5.292","volume":"66","author":"PA Hunter","year":"1982","unstructured":"Hunter PA et al (1982) Corneal graft rejection: a new rabbit model and cyclosporin-A. Br J Ophthalmol 66(5):292\u2013302","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"137_CR63","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00168265","volume":"62","author":"JC Hill","year":"1986","unstructured":"Hill JC (1986) The use of systemic cyclosporin a in human corneal transplantation: a preliminary report. Doc Ophthalmol 62(4):337\u2013344","journal-title":"Doc Ophthalmol"},{"issue":"5","key":"137_CR64","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0002-9394(89)90494-7","volume":"107","author":"JC Hill","year":"1989","unstructured":"Hill JC (1989) The use of cyclosporine in high-risk keratoplasty. Am J Ophthalmol 107(5):506\u2013510","journal-title":"Am J Ophthalmol"},{"key":"137_CR65","volume-title":"Immunology of corneal transplantation","author":"HJ Volker-Dieben","year":"1995","unstructured":"Volker-Dieben HJ, D\u2019Amaro J, Van Slooten H et al (1995) The effect of cyclosporin A on corneal graft survival. In: Zieruth M (ed) Immunology of corneal transplantation, 9th edn. Aeolus Press, Buren","edition":"9"},{"issue":"6","key":"137_CR66","first-page":"432","volume":"1","author":"R Sundmacher","year":"1992","unstructured":"Sundmacher R, Reinhard T, Heering P (1992) Six years\u2019 experience with systemic cyclosporin A prophylaxis in high-risk perforating keratoplasty patients. A retrospective study. Ger J Ophthalmol 1(6):432\u2013436","journal-title":"Ger J Ophthalmol"},{"key":"137_CR67","unstructured":"Maeda N, Hosotani H, Ikeda T et al (1992) Effect of oral cyclosporine in high-risk corneal transplantation. Jpn J Clin Ophthalmol 46(1):1071\u20136"},{"key":"137_CR68","first-page":"763","volume":"48","author":"S Yamagami","year":"1994","unstructured":"Yamagami S, OhyaT Tsuru T et al (1994) Effect of cyclosporine following penetrating keratoplasty. Jpn J Clin Ophthalmol 48:763\u2013767","journal-title":"Jpn J Clin Ophthalmol"},{"issue":"1","key":"137_CR69","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0161-6420(13)31253-6","volume":"101","author":"JC Hill","year":"1994","unstructured":"Hill JC (1994) Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy. Ophthalmology 101(1):128\u2013133","journal-title":"Ophthalmology"},{"issue":"Pt 4","key":"137_CR70","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/eye.1995.99","volume":"9","author":"JC Hill","year":"1995","unstructured":"Hill JC (1995) Systemic cyclosporine in high-risk keratoplasty: long-term results. Eye (Lond) 9(Pt 4):422\u2013428","journal-title":"Eye (Lond)"},{"issue":"3","key":"137_CR71","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00007890-198803000-00030","volume":"45","author":"K Miller","year":"1988","unstructured":"Miller K et al (1988) Successful engraftment of high-risk corneal allografts with short-term immunosuppression with cyclosporine. Transplantation 45(3):651\u2013653","journal-title":"Transplantation"},{"issue":"6","key":"137_CR72","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1055\/s-2008-1046313","volume":"197","author":"V Rossa","year":"1990","unstructured":"Rossa V, Sundmacher R, Heering P (1990) Preventive systemic cyclosporin A in risk keratoplasty. Klin Monbl Augenheilkd 197(6):466\u2013469","journal-title":"Klin Monbl Augenheilkd"},{"issue":"Suppl 1","key":"137_CR73","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1007\/BF02343059","volume":"234","author":"T Reinhard","year":"1996","unstructured":"Reinhard T, Sundmacher R, Heering P (1996) Systemic ciclosporin A in high-risk keratoplasties. Graefes Arch Clin Exp Ophthalmol 234(Suppl 1):S115\u2013S121","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"137_CR74","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s003470050146","volume":"94","author":"T Reinhard","year":"1997","unstructured":"Reinhard T et al (1997) Preventive systemic cyclosporin A after keratoplasty at increased risk for immune reactions as the only elevated risk factor. Ophthalmologe 94(7):496\u2013500","journal-title":"Ophthalmologe"},{"issue":"12","key":"137_CR75","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1136\/bjo.85.12.1464","volume":"85","author":"AC Poon","year":"2001","unstructured":"Poon AC et al (2001) Systemic cyclosporin A in high risk penetrating keratoplasties: a case-control study. Br J Ophthalmol 85(12):1464\u20131469","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"137_CR76","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0021-5155(99)00223-3","volume":"44","author":"K Inoue","year":"2000","unstructured":"Inoue K et al (2000) Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty. Jpn J Ophthalmol 44(3):302\u2013305","journal-title":"Jpn J Ophthalmol"},{"issue":"7","key":"137_CR77","first-page":"507","volume":"20","author":"PY Robert","year":"1997","unstructured":"Robert PY et al (1997) Treatment with cyclosporin A, with low doses, in high-risk penetrating keratoplasties. A bi-centric study of 90 cases. J Fr Ophtalmol 20(7):507\u2013514","journal-title":"J Fr Ophtalmol"},{"issue":"1","key":"137_CR78","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ajo.2011.01.019","volume":"152","author":"J Shimazaki","year":"2011","unstructured":"Shimazaki J et al (2011) Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation. Am J Ophthalmol 152(1):33\u201339 e1","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"137_CR79","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00007890-198011000-00009","volume":"30","author":"WP Homan","year":"1980","unstructured":"Homan WP et al (1980) Effect of cyclosporin A upon second-set rejection of rat renal allografts. Transplantation 30(5):354\u2013357","journal-title":"Transplantation"},{"issue":"2","key":"137_CR80","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00007890-198102000-00011","volume":"31","author":"A Gratwohl","year":"1981","unstructured":"Gratwohl A, Forster I, Speck B (1981) Skin grafts in rabbits with cyclosporin A: absence of induction of tolerance and untoward side effects. Transplantation 31(2):136\u2013138","journal-title":"Transplantation"},{"issue":"2 Suppl 2","key":"137_CR81","first-page":"29","volume":"20","author":"AD Hess","year":"1988","unstructured":"Hess AD, Esa AH, Colombani PM (1988) Mechanisms of action of cyclosporine: effect on cells of the immune system and on subcellular events in T cell activation. Transplant Proc 20(2 Suppl 2):29\u201340","journal-title":"Transplant Proc"},{"issue":"3","key":"137_CR82","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.eye.6700144","volume":"16","author":"AL Young","year":"2002","unstructured":"Young AL et al (2002) Combined intravenous pulse methylprednisolone and oral cyclosporine A in the treatment of corneal graft rejection: 5-year experience. Eye (Lond) 16(3):304\u2013308","journal-title":"Eye (Lond)"},{"issue":"Pt 4","key":"137_CR83","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/eye.1998.154","volume":"12","author":"DS Lam","year":"1998","unstructured":"Lam DS et al (1998) The use of combined intravenous pulse methylprednisolone and oral cyclosporin A in the treatment of corneal graft rejection: a preliminary study. Eye (Lond) 12(Pt 4):615\u2013618","journal-title":"Eye (Lond)"},{"issue":"5","key":"137_CR84","first-page":"1202","volume":"16","author":"R Margreiter","year":"1984","unstructured":"Margreiter R et al (1984) Cyclosporine in the treatment of acute allograft rejection refractory to high-dose methylprednisolone: results of a prospectively randomized trial. Transplant Proc 16(5):1202\u20131204","journal-title":"Transplant Proc"},{"issue":"5","key":"137_CR85","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0039-6257(90)90110-H","volume":"34","author":"SE Wilson","year":"1990","unstructured":"Wilson SE, Kaufman HE (1990) Graft failure after penetrating keratoplasty. Surv Ophthalmol 34(5):325\u2013356","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"137_CR86","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.survophthal.2009.02.002","volume":"54","author":"E Donnenfeld","year":"2009","unstructured":"Donnenfeld E, Pflugfelder SC (2009) Topical ophthalmic cyclosporine: pharmacology and clinical uses. Surv Ophthalmol 54(3):321\u2013338","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"137_CR87","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/01.ico.0000138841.44926.f8","volume":"24","author":"PY Koay","year":"2005","unstructured":"Koay PY, Lee WH, Figueiredo FC (2005) Opinions on risk factors and management of corneal graft rejection in the United kingdom. Cornea 24(3):292\u2013296","journal-title":"Cornea"},{"issue":"1","key":"137_CR88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00003226-199401000-00001","volume":"13","author":"CS Bouchard","year":"1994","unstructured":"Bouchard CS, Cavanagh HD (1994) The high-risk keratoplasty patient\u2013quo vadis? Cornea 13(1):1\u20133","journal-title":"Cornea"},{"issue":"11","key":"137_CR89","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/archopht.121.11.1577","volume":"121","author":"PJ McDonnell","year":"2003","unstructured":"McDonnell PJ et al (2003) Associations of presbyopia with vision-targeted health-related quality of life. Arch Ophthalmol 121(11):1577\u20131581","journal-title":"Arch Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-015-0137-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-015-0137-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-015-0137-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T14:25:33Z","timestamp":1567261533000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-015-0137-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,13]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["137"],"URL":"https:\/\/doi.org\/10.1007\/s10792-015-0137-8","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,13]]}}}